Wednesday, April 29, 2015 8:18:26 AM
By BNK Invest, April 28, 2015, 11:45:24 AM EDT AAA
Vote up Comment More Sharing ServicesShare|Share on facebookShare on twitterShare on emailShare on print Subscribe
Looking back to 160 days ago, Rockwell Medical, Inc (Symbol: RMTI) priced a 6,500,000 share secondary stock offering at $9.00 per share. Buyers in that offering made a considerable investment into the company, expecting that their investment would go up over the course of time and based on early trading on Tuesday, the stock is now 9.3% above the offering price.
Investors who did not participate in the offering but would be a buyer of RMTI at a cheaper price, might benefit from considering selling puts among the alternative strategies at their disposal. One interesting put contract in particular, is the November put at the $8 strike, which has a bid at the time of this writing of 85 cents. That would result in a cost basis of $7.15 per share before broker commissions in the scenario where the contract is exercised. If the contract is never exercised, the put seller would still keep the premium, which represents a 10.6% return against the $8.00 purchase commitment, or a 18.8% annualized rate of return (at Stock Options Channel we call this the YieldBoost ).
Secondaries can often present buying opportunities for bullish investors interested in purchasing shares, because the sudden extra supply of stock tends to require that the offering be priced at an attractive discount to where the stock had previously been trading before the offering announcement. That can also introduce near-term volatility which improves the premiums a put seller can achieve. Selling a put does not give an investor access to RMTI's upside potential the way owning shares would, because the put seller only ends up owning shares in the scenario where the contract is exercised. The chart below shows the one year performance of RMTI shares, versus its 200 day moving average:
Rockwell Medical, Inc Chart
Looking at the chart above, RMTI's low point in its 52 week range is $8.10 per share, with $12.47 as the 52 week high point - that compares with a last trade of $10.19.
RMTI makes up 1.63% of the SPDR S&P Health Care Equipment ETF (Symbol: XHE)
Read more: http://www.nasdaq.com/article/use-options-for-a-chance-to-buy-rmti-at-a-30-discount-cm470250#ixzz3YhSpHsHY
Recent RMTI News
- Rockwell Medical Named a Fortune 'Best Workplaces in Manufacturing & Production' • Business Wire • 09/18/2024 08:30:00 PM
- Rockwell Medical Named a Fortune 'Best Workplaces in Manufacturing & Production' • Business Wire • 09/18/2024 10:00:00 AM
- Rockwell Medical Announces Product Purchase Agreement with Leading At-Home and Acute Care Dialysis Provider • Business Wire • 09/09/2024 10:00:00 AM
- Rockwell Medical Enters into Multi-Million Dollar Distribution Agreement with Nipro Medical Corporation • Business Wire • 09/03/2024 10:00:00 AM
- Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] • Edgar (US Regulatory) • 08/20/2024 06:22:53 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/08/2024 08:51:17 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/08/2024 11:00:57 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/08/2024 10:14:18 AM
- Rockwell Medical Reports Profitability on a Cash Flow and Adjusted EBITDA Basis in the Second Quarter of 2024 • Business Wire • 08/08/2024 10:00:00 AM
- Rockwell Medical Launches Convenience Pack to Support Home Hemodialysis and Acute Dialysis Facilities • Business Wire • 08/07/2024 10:00:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/15/2024 10:50:39 AM
- Rockwell Medical to Present at the H.C. Wainwright 3rd Annual Kidney Virtual Conference • Business Wire • 07/15/2024 10:45:00 AM
- Rockwell Medical to Release Second Quarter 2024 Results on Thursday, August 8, 2024 • Business Wire • 07/11/2024 10:00:00 AM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 05/30/2024 11:51:54 PM
- Rockwell Medical Promotes Tim Chole to Chief Commercial Officer • Business Wire • 05/30/2024 10:00:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/23/2024 11:10:26 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/23/2024 11:07:55 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/23/2024 11:06:52 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/23/2024 11:05:06 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/23/2024 11:02:35 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/23/2024 09:12:01 PM
North Bay Resources Commences Operations at Bishop Gold Mill, Inyo County, California; Engages Sabean Group Management Consulting • NBRI • Sep 25, 2024 9:15 AM
CEO David B. Dorwart Anticipates a Bright Future at Good Gaming Inc. Through His Most Recent Shareholder Update • GMER • Sep 25, 2024 8:30 AM
Cannabix Technologies and Omega Laboratories Inc. Advance Marijuana Breathalyzer Technology - Dr. Bruce Goldberger to Present at Society of Forensic Toxicologists Conference • BLOZF • Sep 24, 2024 8:50 AM
Integrated Ventures, Inc Announces Strategic Partnership For GLP-1 (Semaglutide) Procurement Through MedWell USA, LLC. • INTV • Sep 24, 2024 8:45 AM
Avant Technologies Accelerates Creation of AI-Powered Platform to Revolutionize Patient Care • AVAI • Sep 24, 2024 8:00 AM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM